Saturday, August 31, 2019

Very-late-onset Friedreich’s ataxia: diagnosis in a kindred with late-onset cerebellar ataxia

›
Conor Fearon, Roisin Lonergan, Damien Ferguson, Susan Byrne, David Bradley, Yvonne Langan, Janice Redmond; Practical Neurology Published Onl...
Thursday, August 29, 2019

Iron Pathophysiology in Friedreich’s Ataxia

›
Li K. (2019) Iron Pathophysiology in Friedreich’s Ataxia. In: Chang YZ. (eds) Brain Iron Metabolism and CNS Diseases. Advances in Experiment...
Wednesday, August 28, 2019

Oral mobility reflects rate of progression in advanced Friedreich’s ataxia

›
Borel, S. , Gatignol, P. , Smail, M. , Monin, M. , Ewenczyk, C. , Bouccara, D. and Durr, A. (2019). Ann Clin Transl Neurol. doi:10.1002/acn3...
Friday, August 23, 2019

Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures

›
Christian Hohenfeld, Imis Dogan, Robin Schubert, Claire Didszun, Ludger Schöls, Matthis Synofzik, Ilaria A. Giordano, Thomas Klockgether, Jö...
Saturday, August 17, 2019

Measuring peripheral nerve involvement in Friedreich’s ataxia

›
Creigh, P. D., Mountain, J. , Sowden, J. E., Eichinger, K. , Ravina, B. , Larkindale, J. and Herrmann, D. N. (2019). Ann Clin Transl Neurol....

Exicure, Inc.Announced important preclinical data supporting development of SNA technology in the central nervous system (CNS)

›
Exicure, Inc. (Nasdaq: XCUR), 8 Aug 2019, pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) co...
Thursday, August 15, 2019

Mitochondrial disorders and drugs: what every physician should know

›
Orsucci D, Caldarazzo Ienco E, Siciliano G, Mancuso M.; Drugs in Context 2019; 8: 212588. DOI: 10.7573/dic.212588 In this review we discus...
Wednesday, August 14, 2019

Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development

›
Natalia Robledinos-Antón, Raquel Fernández-Ginés, Gina Manda, and Antonio Cuadrado, Oxidative Medicine and Cellular Longevity, vol. 2019, Ar...
Tuesday, August 13, 2019

Compassionate use of human recombinant insulin-like growth factor-1 therapy in Friedreich's ataxia

›
García Ron A, Rodriguez Mesa M. , Compassionate use of human recombinant insulin-like growth factor-1 therapy in Friedreich's ataxia del...
Sunday, August 11, 2019

Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders

›
Arun Kumar Verma & Eshan Khan & Sonali R. Bhagwat & Amit Kumar; Mol Neurobiol (2019). doi:10.1007/s12035-019-01724-4 In recent...